|
|
"Medications to be Used in the Elderly" A Statewide Clinical Recommendation on Potentially Inappropriate Medications*†
Medication Detail: A - Ci
Usage Ratings
|
Level 1:
|
Safer alternatives may exist; use of this medication is not suggested in the elderly
|
|
Level 2:
|
Medication use should be considered only in a specific patient population as appropriate
|
|
Level 3:
|
Medication use is not suggested in naïve patients; evaluate current therapy for tolerance and adverse effects
|
|
Drug1,2,3
|
Drug Class
|
Concern(s)1,2,3,4
|
Alternative Suggestions‡§1,2,3,4
|
|
alprazolam doses >2mg (XANAX®)
|
Benzodiazepines, Short-Acting
|
Due to sensitivity in the elderly, total daily doses should not exceed the suggested maximum dose of 2mg
|
(Algorithm A) Anxiety: taper off benzodiazepine and add buspirone, lorazepam <3mg/day, oxazepam <60mg/day5 (Algorithm I) Insomnia: sleep hygiene, trazodone, temazepam, zolpidem, zaleplon, eszopiclone, ramelteon5,6,7
|
|
amiodarone (CORDARONE®)
|
Anti-Arrhythmic Agents, Class III
|
QT interval prolongation, Torsades de pointes, uncertain effectiveness, Boxed Warning: pulmonary toxicity, hepatotoxicity, pro-arrhythmic events
|
(Algorithm A/F) Atrial Fibrillation, Rate Control; Left Ventricular Ejection Fraction (LVEF) <40%: metoprolol (extended release), carvedilol, bisoprolol + digoxin, (amiodarone may be used if alternative suggestions have failed)8,22 Atrial Fibrillation, Rate Control; LVEF ≥ 40%: atenolol, metoprolol, propranolol, non-dihydropyridine CCB (diltiazem, verapamil), digoxin (no more than 125mcg/day)8,22; Atrial Fibrillation, Rhythm Control (no or minimal heart disease): propafenone, flecainide, sotalol (amiodarone may be used if alternative suggestions have failed)8,22; Atrial Fibrillation, Rhythm Control (heart disease present): propafenone, flecainide, dofetilide, sotalol8,22
|
|
amitriptyline (ELAVIL®)
|
Antidepressants, Tricyclic
|
Anticholinergic effects, sedative effects
|
(Algorithm P) Pain, Neuropathic: topical (capsaicin, menthol), lidocaine patch, tricyclic antidepressant without active metabolites (nortriptyline), gabapentin, pregabalin9; Depression: psychotherapy, SSRI, SNRI, bupropion, mirtazapine10; (Algorithm I) Insomnia: sleep hygiene, trazodone, temazepam, zolpidem, zaleplon, eszopiclone, ramelteon5,6,7
|
|
amphetamines
|
Amphetamines
|
Hypertension, angina, myocardial infarction, Boxed Warning: High abuse potential, dependency
|
Depression: psychotherapy, SSRI, SNRI, bupropion, mirtazapine11; Weight Control: diet and lifestyle modifications
|
|
anorexic agents
|
Anorexic Agents
|
Dependency, hypertension, angina, myocardial infarction
|
Weight Control: diet and lifestyle modifications
|
|
barbiturates
|
Sedatives, Barbiturate
|
Dependency, sedative effects
|
(Algorithm I) Insomnia: sleep hygiene, trazodone, temazepam, zolpidem, zaleplon, eszopiclone, ramelteon5,6,7 (phenobarbital may be used if controlling seizures)
|
|
belladonna alkaloids (DONNATAL® and others)
|
Antispasmodic Agents, Gastrointestinal
|
Anticholinergic effects, uncertain effectiveness
|
Pain, IBS/GI: APAP, fiber (psyllium), simethicone, (belladonna may be used in IBS due to chronic opioid therapy)9,12; (Algorithm C) Constipation: increase fluids and fiber intake, psyllium, polyethylene glycol, stool softener (docusate), glycerin suppository12; Diarrhea: loperamide, cholestyramine12
|
|
bisacodyl (DULCOLAX®)
|
Laxatives, Stimulant
|
Bowel dysfunction
|
(Algorithm C) Constipation: increase fluids and fiber intake, psyllium, polyethylene glycol, stool softener (docusate), glycerin suppository, (biscodyl may be used in elderly or hospice patients taking medications that may cause constipation and have failed alternative suggestions)12
|
|
carisoprodol (SOMA®)
|
Musculoskeletal Agents, Skeletal Muscle Relaxant
|
Anticholinergic effects, sedative effects, weakness, uncertain effectiveness
|
Spasticity: treat underlying problem, correct seating/footwear, APAP, NSAID+PPI, baclofen, tizanidine13
|
|
chlorazepate (TRANXENE®)
|
Benzodiazepines, Long-Acting
|
Long half-life, anticholinergic effects, sedative effects
|
(Algorithm A) Anxiety: taper off benzodiazepine and add buspirone, lorazepam <3mg/day, oxazepam <60mg/day5; (Algorithm I) Insomnia: sleep hygiene, trazodone, temazepam, zolpidem, zaleplon, eszopiclone, ramelteon5,6,7
|
|
chlordiazepoxide (LIBRIUM®), chlordiazepoxide-amitriptyline (LIMBITROL®)
|
Benzodiazepines, Long-Acting Antidepressant Agents, Tricyclic
|
Long half-life, anticholinergic effects, sedative effects, increased risk of falls
|
(Algorithm A) Anxiety: taper off benzodiazepine and add buspirone, lorazepam <3mg/day, oxazepam <60mg/day5; (Algorithm I) Insomnia: sleep hygiene, trazodone, temazepam, zolpidem, zaleplon, eszopiclone, ramelteon5,6,7
|
|
chlorpheniramine (CHLORTRIMETON®)
|
Antihistamines, H1 Receptor Antagonist
|
Anticholinergic effects
|
(Algorithm A/R) Allergic Rhinitis: nasal corticosteroid, opthalmic antihistamine, fexofenadine, loratadine, desloratadine, cetirizine, levocetirizine5,14,28
|
|
chlorpromazine (THORAZINE®)
|
Antipsychotic Agents, Typical
|
Increased risk of falls, extrapyramidal symptoms, Boxed Warning: increased mortality risk in elderly dementia related patients on typical or atypical antipsychotics
|
(Algorithm N/V) Chemotherapy Induced/Post-Operative Nausea and Vomiting: ondansetron, granisetron, dolasetron, palonosetron, + dexamethasone (chlorpromazine may be used in hospice or schizophrenia patients)15
|
|
chlorpropamide (DIABINESE®)
|
Antidiabetic Agents, Sulfonylurea
|
Long half-life, hypoglycemia, SIADH
|
(Algorithm D) Diabetes Mellitus, Type II: glimepiride, glipizide, glyburide, tolbutamide, (sulfonylureas may be used as add on therapy to metformin and TZDs when appropriate)16,25,27
|
|
chlorzoxazone (PARAFLEX®)
|
Musculoskeletal Agents, Skeletal Muscle Relaxant
|
Anticholinergic effects, sedative effects, weakness, hepatotoxicity, uncertain effectiveness
|
Spasticity: treat underlying problem, correct seating/footwear, APAP, NSAID+PPI, baclofen, tizanidine13
|
|
cimetidine (TAGAMET®)
|
Antiulcer Agents, Histamine 2 Receptor Antagonist
|
CNS adverse effects
|
GI Indications: ranitidine, famotidine, nizatidine, proton pump inhibitor (PPI), (cimetidine may be used in the Emergency Department for allergies)
|
* This information is not intended to supersede your clinical judgment or assessment of your patient; only you, in direct consultation with your patient, can determine if drug therapy benefits outweigh potential risks
† Compilation of evidence-based literature including Arch Int Med 2003;163:2716-2724, reviewed by the PIMs committee, an interdisciplinary committee of health care professionals in New Mexico
‡ Third-party coverage of alternative suggestions may vary
§ Alternative suggestions may be applied to hospice patients, but may not be considered standard of care
|